How to tell if you have a ‘dopamine deficit' and what you can do to reset
Your problem may have to do with your dopamine levels.
In many parts of the world, people are fed media, activities and foods that can cause dopamine to surge and throw the balance off, and that could affect your mental health, according to Dr. Anna Lembke, professor of psychiatry and behavioral sciences at Stanford University School of Medicine, chief of the Stanford Addiction Medicine Dual Diagnosis Clinic and author of 'Dopamine Nation: Finding Balance in the Age of Indulgence.'
Lembke spoke with CNN about what dopamine is, what it does and how you can find better balance.
This conversation has been lightly edited and condensed for clarity.
CNN: What is dopamine exactly?
Dr. Anna Lembke: Dopamine is a chemical we make in our brain. Specifically, it's a neurotransmitter. Neurotransmitters allow for fine-tuned regulation of electrical circuits. Basically, our brain is a bunch of electrical circuits, a bunch of wires in the form of neurons that conduct electrical signals that allow for information processing — the job of our brains.
Dopamine has many functions, but in the last 75 years or so, it's been identified as a key player in pleasure, reward and motivation. It's not the only neurotransmitter involved in that process, but it has become a kind of common currency for neuroscientists to measure the reinforcing potential of different substances and behaviors.
CNN: How does dopamine impact our mental health?
Lembke: It plays a central role in the phenomenology of addiction. Addiction is a brain disease where there's dysregulation in a specific reward pathway, a specific circuit in the brain, and dopamine plays a critical role in the brain's reward pathway.
When we do something that's reinforcing, that releases dopamine in the reward pathway and tells our brain, 'Oh, that's something you need to do more of. That's important for survival.'
The highly reinforcing substances and behaviors that we have engineered and have access to now are overwhelming the system. (They) release so much dopamine all at once in the reward pathway that the brain has to adapt or compensate by downregulating dopamine transmission.
The result is that, over time, we can enter into a chronic dopamine-deficit state, where we have essentially changed our hedonic or joy set point. Now we need more of our reward — and more potent forms –– not to feel good, but just to stop feeling bad. And when we're not 'using,' we're experiencing the universal symptoms of withdrawal from any addictive substance or behavior like anxiety, irritability, insomnia, dysphoria and craving.
CNN: Does this just affect people who have an addiction to drugs or alcohol?
Lembke: We're all now kind of on the spectrum of compulsive overconsumption, moving toward addiction, which is resetting our hedonic threshold –– or joy set point. We need more and more of these reinforcers to feel any pleasure at all, and when we're not using, we're dysphoric, we're irritable, we can't sleep.
CNN: What kinds of things risk putting us into dopamine deficit?
Lembke: A lot of different things release dopamine in the reward pathway, including things that are good for us, like learning or spending time with friends.
It's not that dopamine is the villain here, that dopamine release is bad –– not at all. The problem is that we've now engineered old-fashioned drugs to be more potent than ever before, and we've also created drugs that never existed before, like digital media, like 'drugified' foods. We've even taken healthy behaviors like exercise and drugified them by (tracking) ourselves and ranking ourselves and adding in social media and social comparisons.
We're now seeing more and more and more people addicted to social media, online pornography, online gambling, video games and all manner of addictive digital media. There's emerging evidence that these digital media activate the same reward pathways as drugs and alcohol and cause the same kinds of dysregulations as we see in other addictions.
It's the same thing with sugar. Ultraprocessed foods cause dopamine release, and the reward pathway leads to the same kinds of behaviors as when people get addicted to drugs and alcohol. There's a growing consensus that it's basically the same disease process, just with a different object of desire or reward.
CNN: How can we find out if a substance or behavior is problematic?
Lembke: When we look at what makes something addictive, there are several factors. One is potency, which refers to how much dopamine is released in the reward pathway and how quickly it's released. But other factors are simple things like access.
We know that the easier it is to access a reinforcing substance or behavior, the more likely people are to use it and hence get addicted to it. We now live in this world of very easy, frictionless access to a lot of rewarding substances and behaviors.
Digital media in particular is a 24/7 mobile access — anytime, anywhere, to an almost infinite source.
The other thing that makes something addictive is the quantity and frequency of exposure. The more dopamine hits the brain gets, the more likely it is to change and adapt in a way that can create a disease of addiction. (Social media algorithms are) actually engineered to overcome tolerance and create novelty, to encourage people to keep searching for the same or similar rewards as what they've already viewed but hopefully a little bit better.
The criteria for diagnosing addiction are pretty much the same across different definitions. You're looking for the four C's: out-of-control use, compulsive use, craving and consequences — especially continued use despite consequences — as well as the physiologic criteria that indicate biological dependence. Those would be tolerance, needing more (or more potent forms) over time to get the same effect, and withdrawal when you try to stop using.
CNN: What can we do to address dopamine deficit?
Lembke: What I recommend is a 30-day abstinence trial, colloquially called a 'dopamine fast,' from the drug of choice. Not from all rewards but just from the problematic substance or behavior to see how difficult it is to stop — and also to see if you feel better after four weeks.
Why four weeks? Because that's, on average, the amount of time it takes to reset reward pathways, at least phenomenologically. I always warn people, they're going to feel worse before they feel better. But if they get through the first 10 to 14 days, often they will feel much better.
After the abstinence trial, when people want to go back to using, they just need to be very specific about what they're going to use, how much, how often, in what circumstances, how they're going to track it, and what their red flags will be for slipping back into old habits.
Then they can reevaluate whether they can really use in moderation. When it comes to food, obviously, people can't abstain, and nor should they try. But they can abstain from sugar. They can abstain from ultraprocessed foods.
How do we engage in pleasurable things but stop before we get to dopamine deficit?
Lembke: It's not about not having pleasure in life; it is about resetting the balance so that simple pleasures are rewarding again. That is not going to happen if people are constantly indulging in these frictionless, high-potency rewards.
I talk a lot about 'self-binding' and making sure we don't constantly surround ourselves with easy access to these high-potency, cheap pleasures so we don't get into that problem in the first place.
But it takes intentionality because we live in a world where we're constantly being invited to consume, and we're told that the more we consume, the happier we'll be. So, it does take planning and intentionality to create barriers between ourselves and the many drugs out there.
Self-binding can mean physical barriers. If the issue is food, not having ultraprocessed food or sugary food in the house. If it's cannabis, not having pot in the house, not having alcohol. Now, if it's some form of digital media, you can use time as a self-binding strategy: 'I'm only going to use on these days for this amount of time with these people.'
Other people are a very important form of self-binding. We tend to do what those around us are doing, so try to hang out with people who are using substances and behaviors in a way that you want to use them.
Sign up for CNN's Stress, But Less newsletter. Our six-part mindfulness guide will inform and inspire you to reduce stress while learning how to harness it.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
The Tiny Habit That Could Be Fueling Your Anxiety Without You Knowing It
Chances are you don't realize the impact anxiety can have on guys. Studies continuously show that women are twice as likely as men to be diagnosed with an anxiety disorder–but that doesn't mean you're immune. Researchers can't explain the causes of this disparity, but believe guys may feel pressured to exhibit anxious feelings in ways that seem more masculine. 'I think the biggest thing is men are socialized not to show anxiety,' said Carmen McLean, PhD, a researcher and clinical associate professor at Stanford University's Department of Psychiatry. 'Socializing to show agency and self-efficiency dissuades from showing anxiety.' This is one reason anxiety is often accompanied by substance abuse and other 'internalizing disorders, ' said McLean. Sometimes these signs can be subtle, meaning it's especially important to recognize symptoms of anxiety disorders specific to males. Some clues—nervousness, dread over impending danger and rapid breathing—are common across gender lines, but these five manifestations of anxiety disproportionately impact men: Men with social anxiety disorder are more likely to fear dating and are more commonly single, separated or divorced, according to an analysis of survey information from Columbia University. 'Men are supposed to take the lead in dating,' explained Stefan G. Hofmann, PhD and psychology professor at Boston University who researches anxiety. 'The male is the one who is expected to take the first step. That puts them in a performance situation.' Even in the age of apps, men are typically the pursuer. On OkCupid, males are three times more likely to send a first message in an opposite-sex exchange. This means constantly offering yourself up for evaluation and rejection–an anxiety-inducing prospect. 'It's a challenge for people who don't like to play that game,'said Hofman. Plus, some agonize over being chronically single–with reason–David Ezell, clinical director of Darien Wellness, a psychology clinic in Connecticut, told Men's Health. 'Men really benefit from marriage,' Ezell said. 'They're less likely to be sick. They're less likely to be hospitalized. They're hospitalized for shorter stays if they are hospitalized.' Also, marriage is a status symbol, a sign of 'maturation,' said Ezell. With so much at risk, dating and bachelorhood are significant sources of stress in men with anxiety. Men drink and use drugs to relieve anxiety more often than women, according to the same Columbia University study. Research has consistently shown a link between substance abuse and mental health disorders, particularly in men. 'They are looking for medication,' said Ezell. He explains a glass of booze pairs well with the 'I-can-fix-it-myself' attitude associated with masculinity because it doesn't require medical assistance and may seem like a socially acceptable way to ease stress. 'Alcohol is a very effective drug,' said Hofmann. 'It's why it's so popular.' Think about college students who 'pre-game" by drinking at a dorm or with a small group of friends before going to larger parties. They may not realize it, but this helps manage the anxiety of socializing. Guys who forego professional treatment may instead turn to drugs or heavy drinking to cope with anxiety–and this may be a doorway to addiction. In some men, anxiety may manifest as rage or anger. 'It's much more acceptable,' said McLean. While women may find support from friends or mental health professionals, guys often let their feelings build up until they hit a breaking point–and then the flood gates open. 'Because emotions don't get expressed [by men], because anxiety isn't expressed in a healthy way, there are busts of anger as a result,' said Ezell. 'I think anger is considered decisive.' If typical signs of anxiety, like nervousness or fear, are discouraged in men, anger is their only acceptable emotional response. In another study of survey data from Columbia University, men were more likely than women to experience relationship strain from worrying. This could be because women are more likely to have a circle of close friends, whereas men tend to have few confidants who can provide support through emotional distress. 'Men tend to rely on romantic partners for stress,' said Hofman. This can be a burden, he explained. Sociologist Eli J. Finkel further detailed the risk of putting all that psychological dependence on one person in his book, The All-Or-Nothing Marriage. Finkel argued that modern relationships are tense because people seek comfort, growth, purpose, and a host of other needs from romantic partnerships. Prior generations sought comfort in an entire network of family and friends. 'Marriage for a long time served a set and relatively limited array of different functions for us,' Finkel told the NPR podcast Hidden Brain. 'And over time we've piled more and more of these emotional and psychological functions." Anxious men might burn out their few outlets (or only outlet) for social support quickly. Ezell's practice is located in Darien, Connecticut, a bedroom community for hedge fund managers and Wall Street executives. With a median family income of $208,125, it's frequently named one of the wealthiest municipalities in the United States. Despite their success, Ezell has clients who are riddled with anxiety over what they haven't accomplished. 'My clients make a lot of money,' said Ezell. 'They are still not happy and want to know why.' Guys are often anxious about getting ahead of peers, he said. If a friend winters in Aspen, his client wants to winter in the Alps. There is a particular pressure in status attainment—and status advancement—that fuels anxiety disorders for many. 'We are very grateful by getting things,' Ezell said, 'but we get acclimated to that status very quickly. If I am eating well; I want to be eating better.' You Might Also Like The Best Hair Growth Shampoos for Men to Buy Now 25 Vegetables That Are Surprising Sources of Protein
Yahoo
21 minutes ago
- Yahoo
Military experts weigh in on China's new mosquito-like spy drone
Last month, China unveiled a mosquito-like spy drone designed for covert military operations. The drone's size and weight could limit its uses on the battlefield, military analysts told BI. It could still prove to be an effective new surveillance tool, experts say. Last month, China's National University of Defense Technology unveiled a new spy drone designed to look like a mosquito. Showcased on the state-run CCTV-7 military broadcaster, the micro-drone appeared to be roughly the size of a human fingernail and featured tiny, leaf-like wings and thin, wiry legs. While it may not look as impressive as some of the bigger unmanned systems coming out of Ukraine, its stick-thin body is said to be equipped for a range of covert surveillance and military operations. "As a drone to surveil buildings, especially on the inside, I can imagine it being quite useful for video feeds," Herb Lin, a senior research scholar at Stanford's Center for International Security and Cooperation, told Business Insider. But its small size may limit its uses on the battlefield. "If it's real, and powered conventionally (with a battery), its longevity in the air will be limited by battery capacity," Lin said. "Also, it's very light, and therefore easily buffeted by winds. These factors suggest it isn't particularly useful for wide-area surveillance." Drones can be highly sensitive to weather, in particular strong winds, rain, snow, cold weather, and fog. And the smaller an aerial drone is, the more susceptible it is to such conditions, Samuel Bendett, an advisor with the Center for Naval Analyses and drone expert, said. "Even indoors, there can be conditions that could interfere with this drones' performance, such as even a slight breeze, an air flow from an AC, an open window, or other obstacles." Communications are another issue to consider, Bendett continued, as the drone's size means it's unlikely to be able to carry much advanced equipment. "While it is technically possible to build a tiny UAV like the one displayed by the Chinese developers, its actual performance is likely to greatly vary," he said. Others say that the new drone is a sign of China's continuing innovation in the sector. Michael Horowitz, a senior fellow for technology and innovation at the Council on Foreign Relations, said it showed "Chinese researchers in particular want to push forward technological innovation in drones." It remains unclear how real the capability is, how soon China could field the tech, or the type of missions it could use them for, he added. Read the original article on Business Insider
Yahoo
21 minutes ago
- Yahoo
Skye Bioscience Highlights Nimacimab's Promise in Obesity Treatment, Anticipates Phase 2a Data
Skye Bioscience Inc. (NASDAQ:SKYE) is one of the best hot stocks to buy according to Wall Street analysts. On June 23, Skye Bioscience unveiled its 'Anatomy of Progress' nimacimab development update video series. This coincided with the presentation of data related to nimacimab at the American Diabetes Association's/ADA 85th Scientific Sessions, which was held from June 20 to 23 this year in Chicago, Illinois. The four-part 'Anatomy of Progress' video series highlights unmet needs in obesity treatment, the benefits of nimacimab as a peripheral CB1-receptor-targeting antibody for healthy weight loss, and its development progress. Nimacimab's unique mechanism targets receptors in the periphery while being greater than 99% excluded from the brain. This peripheral restriction aims to deliver weight loss and metabolic benefits similar to first-gen CB1 inhibitors, but without the neuropsychiatric side effects that plagued earlier small-molecule counterparts. A scientist in the lab, researching the development of biopharmaceutical monoclonal antibody drugs. Skye Bioscience is currently conducting a Phase 2a clinical trial in obesity for nimacimab, which is a negative allosteric modulating antibody that peripherally inhibits CB1. This study is also assessing nimacimab in combination with a GLP-1R agonist (Wegovy). Interim data from the Phase 2a clinical trial are expected in late Q3 or early Q4 2025, after the initial patient cohort completes a 26-week treatment period. Skye Bioscience Inc. (NASDAQ:SKYE) is a clinical-stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors/GPCRs to treat obesity and metabolic diseases. While we acknowledge the potential of SKYE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data